Released Feb 23, 2011, after the close
10-K filed Feb 23, 2011, 54 days after period end · 0000950123-11-017213
Q4 2010 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net income—
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Cash Flowderived-$8,031,000—
Free Cash Flowderived-$9,070,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
no prior Q4 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protalix BioTherapeutics, Inc. · CIK 1006281 · Engraved from SEC EDGAR